Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: Up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons

Pain. 2013 Sep;154(9):1865-1877. doi: 10.1016/j.pain.2013.06.009. Epub 2013 Jun 12.

Abstract

Spinal nociception can be facilitated by 5-HT2 receptors in neuropathic pain. We investigated the involvement of glutamate receptors in dorsal neuron hyperexcitation that is promoted by 5-HT2B receptor (5-HT2BR) after spinal nerve ligation (SNL) in the rat. Augmentation of C-fiber-evoked potentials by spinal superfusion with 5-HT2BR agonist BW 723C86 in nerve-ligated rats was impeded by co-administration of NMDA receptor (NMDAR) antagonist D-AP5, but not by mGluR1/5 antagonist AIDA or mGluR2/3 antagonist LY 341495. Evoked potentials were increased by cis-ACPD in nerve-injured rats, irrespective of simultaneous 5-HT2BR blockade by SB204741. In uninjured rats, NMDAR agonist cis-ACPD enhanced evoked potentials in the presence of BW 723C86 but not if administered alone or during exposure to protein kinase C γ (PKCγ) inhibitor peptide. Triple immunofluorescence labelings revealed co-localization of NMDAR and 5-HT2BR in PKCγ-expressing perikarya in lamina II neurons. As a result of SNL, PKCγ was transiently and bilaterally up-regulated in synaptic fraction from dorsal horn homogenates, peaking at day 2 and returning to basal levels by day 9. Chronic blockade of 5-HT2BR with selective antagonist SB 204741 after SNL bilaterally decreased the following: (i) PKCγ up-regulation in synaptic fraction, (ii) phosphorylation of NMDAR subunit NR1 (serine 889) in synaptic fraction, and (iii) co-localization of both PKCγ and phosphorylated NR1 with postsynaptic marker PSD-95. Chronic delivery of SB 204741 bilaterally attenuated thermal and mechanical allodynia occurring after SNL, particularly at day 2 post injury. These findings suggest that transient activation of the PKCγ/NMDAR pathway is critically involved in 5-HT2BR-mediated facilitation in the SNL model of neuropathic pain.

Keywords: Electrophysiology; Evoked potentials; Neuropathic pain; Serotonin; Synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Evoked Potentials / drug effects
  • Excitatory Amino Acid Antagonists / pharmacology
  • HEK293 Cells
  • Humans
  • Hyperalgesia / physiopathology
  • Indoles / pharmacology
  • Male
  • Nerve Fibers, Unmyelinated / drug effects
  • Nerve Fibers, Unmyelinated / physiology
  • Neuralgia / metabolism
  • Neuralgia / pathology*
  • Neurons / metabolism*
  • Physical Stimulation
  • Protein Kinase C / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT2B / metabolism*
  • Receptors, N-Methyl-D-Aspartate
  • Serotonin Receptor Agonists / pharmacology
  • Spinal Nerve Roots / pathology*
  • Spinal Nerves*
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • Thiophenes / pharmacology
  • Time Factors
  • Up-Regulation / drug effects
  • Up-Regulation / physiology*

Substances

  • 1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine
  • Enzyme Inhibitors
  • Excitatory Amino Acid Antagonists
  • Indoles
  • Receptor, Serotonin, 5-HT2B
  • Receptors, N-Methyl-D-Aspartate
  • Serotonin Receptor Agonists
  • Thiophenes
  • protein kinase C gamma
  • Protein Kinase C